tradingkey.logo

Bionano Genomics Inc

BNGO
View Detailed Chart
1.150USD
+0.025+2.22%
Close 02/06, 16:00ETQuotes delayed by 15 min
11.19MMarket Cap
LossP/E TTM

Bionano Genomics Inc

1.150
+0.025+2.22%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.22%

5 Days

-11.54%

1 Month

-28.57%

6 Months

-61.67%

Year to Date

-24.84%

1 Year

-79.90%

View Detailed Chart

TradingKey Stock Score of Bionano Genomics Inc

Currency: USD Updated: 2026-02-06

Key Insights

Bionano Genomics Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 132 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.50.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Bionano Genomics Inc's Score

Industry at a Glance

Industry Ranking
132 / 205
Overall Ranking
380 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Bionano Genomics Inc Highlights

StrengthsRisks
Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Growing
The company is in a growing phase, with the latest annual income totaling USD 30.78M.
Overvalued
The company’s latest PE is -0.00, at a high 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 82.31K shares of this stock.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
7.500
Target Price
+566.67%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Bionano Genomics Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Bionano Genomics Inc Info

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Ticker SymbolBNGO
CompanyBionano Genomics Inc
CEOHolmlin (R. Erik)
Websitehttps://bionano.com/
KeyAI